A recent study reveals significant barriers to GLP-1 RA access for diabetes and obesity patients, highlighting racial ...

Experts discuss the importance of initiating blinatumomab treatment for acute lymphoid leukemia in academic centers for ...

The new report from the WHO Global Antimicrobial Resistance and Use Surveillance System is its most extensive, with estimates ...

To help patients navigate access challenges stemming from cuts under President Donald Trump's One Big Beautiful Bill, Brian Mulherin, MD, a hematologist-oncologist at the American Oncology Network, ...

Jenifer Soung, MD, fo Southern California Dermatology, discussed how glucagon-like peptide-1 receptor agonists aid in treating patients with psoriatic disease. Captions are auto-generated.

Energy-based treatments and lasers for skin care have developed tremendously over the past decade, aided by the work of Eliot ...

Lindsey Valenzuela, PharmD, explains how pharmacists can prevent drug interactions and improve coordination for women with arrhythmia and chronic disease.

High costs and uneven insurance coverage keep wearable heart monitors out of reach for many women, according to Lindsey Valenzuela, PharmD, APh, BCACP, vice president of population health integration ...

New evidence is elucidating the apparent link between gut microbiota and idiopathic pulmonary fibrosis (IPF), which may be mediated by circulating inflammatory proteins. The study, which was published ...

Kelley L. Julian, PharmD, BCOP, discusses optimizing myeloma care, addressing barriers in access to intravenous immunoglobulin and innovative therapies at Huntsman Cancer Institute.

Frequent dining out is linked to a higher risk of colorectal cancer, with a dose-response relationship observed. Obesity partially mediates the association between dining out frequency and colorectal ...

Pivoting to GLP-1 RAs, Soung explained that they both decrease appetite and food cravings and are very different from the weight loss drugs of the past in terms of how they work, the fact that they ...